Evaluate the progression of native vessel and graft disease in patients after CABG based on coronary CTA

Evaluate the progression of native vessel and graft disease in patients after CABG based on coronary CTA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500112484

Enrollment

Unknown

Registered

2025-11-14

Start date

2025-10-20

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary atherosclerotic heart disease

Interventions

Case series:None

Sponsors

Beijing Anzhen Hospital Affiliated to Capital Medical University

Lead Sponsor

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who underwent CABG in the reporting hospitals from January 1, 2018 to June 30, 2024 were enrolled, and patients who underwent coronary CTA at least twice in outpatient or inpatient clinics were screened.

Exclusion criteria

Exclusion criteria: Patients who did not undergo coronary CTA or had only one coronary CTA examination were excluded.

Design outcomes

Primary

Measure	Time frame
The amount of change in vascular plaque composition;	—

Secondary

Measure	Time frame
The amount of change in vascular plaque burden;Changes in markers of vascular inflammation;	—

Countries

China

Contacts

Public ContactXiaoming Zhang

Beijing Anzhen Hospital Affiliated to Capital Medical University

zxm223721@163.com+86 188 0130 3721

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026